Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Society of Infectious Diseases Pharmacists

Society of Infectious Diseases Pharmacists
Founded in 1990, the Society of Infectious Diseases Pharmacists (SIDP) is an association of pharmacists and allied healthcare professionals dedicated to promoting the appropriate use of antimicrobial agents.

Latest Partner Content

Alternatives to Vancomycin & Pip/Tazo Combination Therapy
Megan Luther, PharmD, Advanced Health Services research fellow, Providence Veterans Affairs Medical Center, University of Rhode Island, College of Pharmacy, discusses alternative therapies to the acute kidney injury-causing combination of vancomycin piperacillin/tazobactam.
Novel Cephalosporin Agent Shows Promise for Complicated UTIs
A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).
Understanding the Prevalence of Skin and Soft Tissue Infections
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, explains why it’s important to understand the prevalence of skin and soft tissue infections.
Challenges With Classifying and Treating Skin and Soft Tissue Infections
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the biggest challenges associated with classifying and treating skin and soft tissue infections.
Exploring Drug Resistance Among Pathogens That Cause Skin and Soft Tissue Infections
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses which skin and soft tissue infections (SSTIs) are likely to be drug-resistant.
How Can Pharmacists and Physicians Work Together to Optimize Patient Care?
Kerry LaPlante, professor of Pharmacy, University of Rhode Island, adjunct professor of Medicine, Brown University, director of the Rhode Island Infectious Diseases Research Program, and Infectious Diseases Pharmacotherapy Specialist, Providence Veterans Medical Center, discusses how pharmacists and physicians can work together in the hospital setting to optimize patient care.
Incentivizing Antibiotic Development
John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses push and pull incentives that drive antibiotic development.
Reinvigorating the Antibiotic Pipeline
John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses global and national initiatives for the development of new antibiotics.
FEATURED
A recent study from US researchers suggests that liver disease severity and treatment costs for people with hepatitis C (HCV) vary depending on a patient's genotype.